DESIRIAL®, the world’s first treatment for women suffering from vaginal dryness and other symptoms related to vulvo-vaginal atrophy
DESIRIAL® is a treatment based on monophasic cross-linked injectable hyaluronic acid for women suffering from vaginal dryness and other symptoms related to vulvo-vaginal atrophy. DESIRIAL® is available in two gel formulations carefully designed to treat distinct pathologies according to the intended treatment indications:
DESIRIAL® is dedicated to trophic conditions restoration (hydration, elasticity, tone, sensitivity) in the vulvo-vaginal area. It helps to reduce mucosal dryness and strengthen delicate vaginal tissues, making them more supple.
DESIRIAL® PLUS is a more cohesive gel. It can correct morphological vulvar imperfections. In addition to aesthetic corrections, it also fights against functional disorders, such as severe to moderate vaginal atrophy of the labia majora.
DESIRIAL® and DESIRIAL® PLUS are the only injectable hyaluronic acid based medical devices on the market that are CE registered for gynaecological indications, e.g., rejuvenation of the vaginal mucosa, or reconstruction of the labia majora.